N
RLYB icon

Nuveen’s Rallybio RLYB Stock Holding History

Nuveen’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,981
Closed -$118K – 3402
2024
Q1 		$118K Hold
7,981
– – ﹤0.01% 3239
2023
Q4 		$153K Buy
7,981
+344
+5% +$8.41K ﹤0.01% 3248
2023
Q3 		$206K Sell
7,637
-93
-1% -$4.03K ﹤0.01% 3034
2023
Q2 		$350K Buy
7,730
+4,877
+171% +$239K ﹤0.01% 2993
2023
Q1 		$130K Hold
2,853
– – ﹤0.01% 3035
2022
Q4 		$150K Buy
2,853
+52
+2% +$3.07K ﹤0.01% 3072
2022
Q3 		$324K Sell
2,801
-462
-14% -$41.2K ﹤0.01% 3035
2022
Q2 		$197K Buy
3,263
+39
+1% +$2.93K ﹤0.01% 3153
2022
Q1 		$199K Buy
+3,224
New +$267K ﹤0.01% 3195

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen's RLYB Position: Q2 2024 in Review

Nuveen sold out of Rallybio (RLYB) in Q2 2024, closing a stake of 7,981 shares — an estimated $118K sold.

Nuveen first reported a position in RLYB in Q1 2022 and held it in 9 quarters. The position peaked at $350K in Q2 2023. 66 funds tracked by Wall St. Rank hold RLYB as of Q2 2024.

  • Nuveen reported no remaining Rallybio position as of Q2 2024 after selling out during the quarter.
  • Nuveen sold 7,981 Rallybio shares in Q2 2024, an estimated $118K.
  • Nuveen first reported a position in Rallybio in Q1 2022 and held it in 9 quarters.
  • Nuveen's Rallybio position peaked at $350K in Q2 2023.
  • 66 funds tracked by Wall St. Rank held Rallybio as of Q2 2024.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.